Literature DB >> 19280669

Scale-up analysis for a CHO cell culture process in large-scale bioreactors.

Zizhuo Xing1, Brian M Kenty, Zheng Jian Li, Steven S Lee.   

Abstract

Bioprocess scale-up is a fundamental component of process development in the biotechnology industry. When scaling up a mammalian cell culture process, it is important to consider factors such as mixing time, oxygen transfer, and carbon dioxide removal. In this study, cell-free mixing studies were performed in production scale 5,000-L bioreactors to evaluate scale-up issues. Using the current bioreactor configuration, the 5,000-L bioreactor had a lower oxygen transfer coefficient, longer mixing time, and lower carbon dioxide removal rate than that was observed in bench scale 5- and 20-L bioreactors. The oxygen transfer threshold analysis indicates that the current 5,000-L configuration can only support a maximum viable cell density of 7 x 10(6) cells mL(-1). Moreover, experiments using a dual probe technique demonstrated that pH and dissolved oxygen gradients may exist in 5,000-L bioreactors using the current configuration. Empirical equations were developed to predict mixing time, oxygen transfer coefficient, and carbon dioxide removal rate under different mixing-related engineering parameters in the 5,000-L bioreactors. These equations indicate that increasing bottom air sparging rate is more efficient than increasing power input in improving oxygen transfer and carbon dioxide removal. Furthermore, as the liquid volume increases in a production bioreactor operated in fed-batch mode, bulk mixing becomes a challenge. The mixing studies suggest that the engineering parameters related to bulk mixing and carbon dioxide removal in the 5,000-L bioreactors may need optimizing to mitigate the risk of different performance upon process scale-up. (c) 2009 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19280669     DOI: 10.1002/bit.22287

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  23 in total

1.  Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors.

Authors:  Ruth Olmer; Andreas Lange; Sebastian Selzer; Cornelia Kasper; Axel Haverich; Ulrich Martin; Robert Zweigerdt
Journal:  Tissue Eng Part C Methods       Date:  2012-06-04       Impact factor: 3.056

Review 2.  Cell culture processes for monoclonal antibody production.

Authors:  Feng Li; Natarajan Vijayasankaran; Amy Yijuan Shen; Robert Kiss; Ashraf Amanullah
Journal:  MAbs       Date:  2010-09-01       Impact factor: 5.857

3.  Equipment characterization to mitigate risks during transfers of cell culture manufacturing processes.

Authors:  Christian Sieblist; Marco Jenzsch; Michael Pohlscheidt
Journal:  Cytotechnology       Date:  2015-08-01       Impact factor: 2.058

Review 4.  The present state of the art in expression, production and characterization of monoclonal antibodies.

Authors:  Christopher L Gaughan
Journal:  Mol Divers       Date:  2015-08-25       Impact factor: 2.943

5.  The potential of hydrodynamic damage to animal cells of industrial relevance: current understanding.

Authors:  Weiwei Hu; Claudia Berdugo; Jeffrey J Chalmers
Journal:  Cytotechnology       Date:  2011-07-22       Impact factor: 2.058

6.  Protein aggregation and mitigation strategy in low pH viral inactivation for monoclonal antibody purification.

Authors:  Weixin Jin; Zizhuo Xing; Yuanli Song; Chao Huang; Xuankuo Xu; Sanchayita Ghose; Zheng Jian Li
Journal:  MAbs       Date:  2019-09-02       Impact factor: 5.857

7.  Cellular complexity captured in durable silica biocomposites.

Authors:  Bryan Kaehr; Jason L Townson; Robin M Kalinich; Yasmine H Awad; B S Swartzentruber; Darren R Dunphy; C Jeffrey Brinker
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

8.  The use of a stringent selection system allows the identification of DNA elements that augment gene expression.

Authors:  Femke Hoeksema; Rik van Blokland; Michel Siep; Karien Hamer; Tjalling Siersma; Jan den Blaauwen; John Verhees; Arie P Otte
Journal:  Mol Biotechnol       Date:  2011-05       Impact factor: 2.695

9.  The relationship between mTOR signalling pathway and recombinant antibody productivity in CHO cell lines.

Authors:  Raihana Edros; Susan McDonnell; Mohamed Al-Rubeai
Journal:  BMC Biotechnol       Date:  2014-02-17       Impact factor: 2.563

10.  Investigation of the interactions of critical scale-up parameters (pH, pO2 and pCO2) on CHO batch performance and critical quality attributes.

Authors:  Matthias Brunner; Jens Fricke; Paul Kroll; Christoph Herwig
Journal:  Bioprocess Biosyst Eng       Date:  2016-10-17       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.